CA2721749A1 — Combination therapy for glaucoma

USPTO Abstract

Disclosed herein is method of treating glaucoma or ocular hypertension comprising administering a prostaglandin agonist and a second therapeutically active agent to a mammal in need thereof, wherein said second therapeutically active agent is selected from: .beta.-Blockers, Adrenergic Agonists, non-selective adrenergic agonists, .alpha.2-selective adrenergic agonists, Carbonic Anhydrase Inhibitors, Cholinergic Agonists,direct acting cholinergic agonists, chlolinesterase inhibitors, Glutamate Antagonists, Ca2+ channel blockers, Prostamides, Prostaglandins, Cannabinoids, and combinations thereof. Compositions and medicaments containing a combination of these two active agents are also disclosed.